Skip to main content

Table 3 Radiation-absorbed dose estimates for [18F]-tetrafluoroborate based on whole-body imaging in non-human primates

From: Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

Target organ

Dose (mGy/MBq)

 

Mean

SD

Adrenals

1.44E−02

7.1E−05

Brain

4.54E−03

5.3E−04

Breasts

9.52E−03

2.8E−04

Gallbladder wall

1.46E−02

7.1E−05

LLI wall

1.42E−02

1.4E−04

Small intestine

1.43E−02

0.0E+00

Stomach wall

7.86E−02

1.9E−02

ULI wall

1.42E−02

0.0E+00

Heart wall

1.77E−02

7.1E−04

Kidneys

2.25E−02

3.5E−04

Liver

1.27E−02

2.8E−04

Lungs

1.78E−02

2.1E−03

Muscle

1.14E−02

2.1E−04

Ovaries

1.44E−02

0.0E+00

Pancreas

1.85E−02

1.1E−03

Red marrow

1.66E−02

1.4E−04

Osteogenic cells

2.01E−02

4.9E−04

Skin

8.68E−03

2.1E−04

Spleen

1.42E−02

7.8E−04

Testes

1.12E−02

7.1E−05

Thymus

1.18E−02

3.5E−04

Thyroid

4.23E−02

2.1E−04

Urinary bladder wall

4.79E−02

1.5E−02

Uterus

1.56E−02

5.7E−04

Parotid glanda

4.13E−02

2.1E−02

Submandibular glanda

2.74E−02

1.7E−02

Total body

1.18E−02

1.4E−04

Effective dose equivalent (mSv/MBq)

2.21E−02

1.8E−03

Effective dose (mSv/MBq)

2.47E−02

2.8E−03

  1. aAbsorbed dose calculated using the sphere model